Cite

HARVARD Citation

    Ilias, A. et al. (n.d.). P694 Non-medical mandatory reversed and back and forth switch between infliximab and its biosimilar: Early clinical outcomes. Journal of Crohn's and colitis. pp. S461-S462. [Online]. 
  
Back to record